'Next Generation' cancer treatment ready for clinical trials

May 18, 2012

(Medical Xpress) -- A new class of anti-cancer drugs which control the growth and spread of cancers and do so with minimal side effects is being developed by researchers at the University of Sydney.

"These new agents attack a fundamental characteristic of while leaving normal cells alone," said Professor Des Richardson, from the Bosch Institute in Sydney Medical School.

"They work by binding the iron in , preventing them from growing. We believe they have the potential to be an effective new strategy, to be 'next generation' drugs, for a range of cancers including highly aggressive .

Because they do not act on non-cancerous cells these new agents dramatically reduce a range of distressing side effects familiar to people undergoing cancer treatments such as chemotherapy and radiotherapy.

Professor Richardson is the head of the and Chelation Program at the University and has been conducting research in this area since the early 1990s.

The latest research on the chelators is led by post-doctoral researcher and NHMRC Early Career Fellow, Dr. Zaklina Kovacevic.

In the Journal of Biological Chemistry, published today, the researchers outline how these new agents increase the levels of a molecule (NDRG1) which inhibits the spread of cancer, including prostate and colon cancers.

"Together with a recent article in the journal, Antioxidants and Redox Signaling, these studies advance our knowledge of cancer cell biology and how we can target specific molecules to stop cancer progressing," Dr. Kovacevic said.

Professor Richardson is currently in advanced discussions on a licensing deal with an American company for developing the compound to the stage of clinical trials.

"This will present a significant step forward in the fight against cancer and provide cancer sufferers new hope for a better outcome," Professor Richardson said.

"It is a difficult step to go from the often quoted bench to bedside, but it has been greatly helped by the Bosch Institute's Translational Grants program, and by an NHMRC Development Grant."

The Executive Director of the Bosch Institute, Professor Jonathan Stone stated: "For anyone who has been through, or cared for a cancer sufferer through, the purgatory of chemotherapy, the prospect of anti-cancer drugs which are broadly effective but with few side effects is immensely welcome."

Explore further: Match your treatment to your cancer

Related Stories

Match your treatment to your cancer

June 30, 2011
(Medical Xpress) -- New research has uncovered why certain cancers don’t respond to conventional chemotherapy, highlighting the need to match treatments to cancers better.

Silencing a deadly conversation in breast cancer

June 2, 2011
While it is already known that breast cancer cells create the conditions for their own survival by communicating their needs to the healthy cells that surround them, Australian researchers have identified a new way of turning ...

Novel drug combination offers therapeutic promise for hard-to-treat cancers

September 12, 2011
Researchers at Brigham and Women's Hospital (BWH) have identified a new combination of targeted therapies that, together, may treat two aggressive tumor types that until now have not had effective treatments. These findings ...

Mechanism of action behind novel cancer agents targeting tumor cell metabolism discovered

July 26, 2011
(Medical Xpress) -- The discovery of the mechanism of action behind a novel class of anticancer drugs designed to disrupt cancer cell mitochondrial metabolism may be a major step toward furthering clinical trials of the agents. ...

Cell discovery strengthens quest for cancer treatments

February 13, 2012
Fresh insights into how our cells multiply could help scientists develop drugs to treat cancer.

New agents show promise for treating aggressive breast cancers

July 18, 2011
Some of the most aggressive forms of breast cancer are more vulnerable to chemotherapy when it is combined with a new class of anti-cancer agent, researchers from the Walter and Eliza Hall Institute have shown.

Recommended for you

Alternative splicing, an important mechanism for cancer

September 22, 2017
Cancer, which is one of the leading causes of death worldwide, arises from the disruption of essential mechanisms of the normal cell life cycle, such as replication control, DNA repair and cell death. Thanks to the advances ...

'Labyrinth' chip could help monitor aggressive cancer stem cells

September 21, 2017
Inspired by the Labyrinth of Greek mythology, a new chip etched with fluid channels sends blood samples through a hydrodynamic maze to separate out rare circulating cancer cells into a relatively clean stream for analysis. ...

Drug combination may improve impact of immunotherapy in head and neck cancer

September 21, 2017
Checkpoint inhibitor-based immunotherapy has been shown to be very effective in recurrent and metastatic head and neck cancer but only in a minority of patients. University of California San Diego School of Medicine researchers ...

Whole food diet may help prevent colon cancer, other chronic conditions

September 21, 2017
A diet that includes plenty of colorful vegetables and fruits may contain compounds that can stop colon cancer and inflammatory bowel diseases in pigs, according to an international team of researchers. Understanding how ...

New kinase detection method helps identify targets for developing cancer drugs

September 21, 2017
Purdue University researchers have developed a high-throughput method for matching kinases to the proteins they phosphorylate, speeding the ability to identify multiple potential cancer drug targets.

Poliovirus therapy induces immune responses against cancer

September 20, 2017
An investigational therapy using modified poliovirus to attack cancer tumors appears to unleash the body's own capacity to fight malignancies by activating an inflammation process that counter's the ability of cancer cells ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.